Literature DB >> 18282119

1st NCI annual meeting on Clinical Proteomic Technologies for Cancer.

Feng Tao1.   

Abstract

The National Cancer Institute of the US National Institutes of Health established a Clinical Proteomic Technologies Initiative for Cancer (CPTI) in 2006. The first annual meeting organized by the CPTI program provided up-to-date information on the research activities and achievements at its first anniversary of this program. Presentations were made by leaders from the five centers nationwide of the Clinical Proteomic Technology Assessment for Cancer (CPTAC), and other principal investigators funded by the CPTI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282119     DOI: 10.1586/14789450.5.1.17

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  3 in total

1.  Minimum information about a protein affinity reagent (MIAPAR).

Authors:  Julie Bourbeillon; Sandra Orchard; Itai Benhar; Carl Borrebaeck; Antoine de Daruvar; Stefan Dübel; Ronald Frank; Frank Gibson; David Gloriam; Niall Haslam; Tara Hiltker; Ian Humphrey-Smith; Michael Hust; David Juncker; Manfred Koegl; Zoltàn Konthur; Bernhard Korn; Sylvia Krobitsch; Serge Muyldermans; Per-Ake Nygren; Sandrine Palcy; Bojan Polic; Henry Rodriguez; Alan Sawyer; Martin Schlapshy; Michael Snyder; Oda Stoevesandt; Michael J Taussig; Markus Templin; Matthias Uhlen; Silvere van der Maarel; Christer Wingren; Henning Hermjakob; David Sherman
Journal:  Nat Biotechnol       Date:  2010-07       Impact factor: 54.908

Review 2.  Proteomics of gliomas: initial biomarker discovery and evolution of technology.

Authors:  Juliya Kalinina; Junmin Peng; James C Ritchie; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2011-09       Impact factor: 12.300

3.  Magnetic bead processor for rapid evaluation and optimization of parameters for phosphopeptide enrichment.

Authors:  Scott B Ficarro; Guillaume Adelmant; Maria N Tomar; Yi Zhang; Vincent J Cheng; Jarrod A Marto
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.